Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Teva
Boehringer Ingelheim
Covington
Baxter
Colorcon
Cantor Fitzgerald
Healthtrust
Daiichi Sankyo

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,258,027

« Back to Dashboard

Summary for Patent: 4,258,027
Title: Multi-fractionable tablet structure
Abstract:The invention disclosed provides a multi-fractionable tablet structure initially configurated in a unitary dosage while having readily severable sub-dosage units as components thereof. Score markings are positioned variously about the tablet such as along the top and bottom surfaces thereof. Additionally, score markings may appear along opposite vertical side surfaces of the tablet. Special placement of the score markings readily permits alternatively an accurate equal bisectional or trisectional fracture of the tablet as may be desired for patient consumption.
Inventor(s): Ullman; Michael K. (Evansville, IN), David; Stephen T. (Evansville, IN), Gallian; Claude E. (Evansville, IN)
Assignee: Mead Johnson & Company (Evansville, IN)
Application Number:06/121,615
Patent Claim Types:
see list of patent claims
Dosage form;

Drugs Protected by US Patent 4,258,027

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,258,027

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 372853 ➤ Try a Free Trial
Austria A160880 ➤ Try a Free Trial
Australia 533115 ➤ Try a Free Trial
Australia 5647480 ➤ Try a Free Trial
Belgium 882426 ➤ Try a Free Trial
Canada 1133393 ➤ Try a Free Trial
Switzerland 644515 ➤ Try a Free Trial
Cyprus 1311 ➤ Try a Free Trial
Germany 3011680 ➤ Try a Free Trial
Denmark 128580 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
Fuji
McKesson
Boehringer Ingelheim
Citi
Federal Trade Commission
Accenture
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot